Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Biomolecules|January 23, 2024
Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma ComorbiditiesSara Naharro-González, Clara Lorente-Sorolla, José Manuel Rodrigo-Muñoz, et al.
The Lancet. Oncology|May 1, 2018
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trialSonia Pernas, Miguel Martin, Peter A Kaufman, et al.
Frontiers in Genetics|November 18, 2024
An intragenic duplication in the AFF2 gene associated with Cornelia de Lange syndrome phenotypeCristina Lucia-Campos, Ilaria Parenti, Ana Latorre-Pellicer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2022
Clinical and genetic characteristics of Dent's disease type 1 in EuropeCarla Burballa, Gerard Cantero-Recasens, Larisa Prikhodina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancerAugust Vidal, Clara Muñoz, María-José Guillén, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Scientific Reports|July 30, 2021
Clinical relevance of postzygotic mosaicism in Cornelia de Lange syndrome and purifying selection of NIPBL variants in bloodAna Latorre-Pellicer, Marta Gil-Salvador, Ilaria Parenti, et al.
Orphanet Journal of Rare Diseases|February 28, 2021
Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish populationEnrique Rodríguez-Rubio, Helena Gil-Peña, Sara Chocron, et al.
JAMA Oncology|September 28, 2023
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled TrialTae Won Kim, Philippe L Bedard, Patricia LoRusso, et al.
Journal for Immunotherapy of Cancer|March 26, 2022
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumorsRocio Garcia-Carbonero, Miriam Bazan-Peregrino, Marta Gil-Martín, et al.
Pageof 24